Advances in bio-solutions are revolutionizing the pharmaceutical industry. Japan is at the forefront of the development and adoption of biopharma ingredients and this event focuses on the latest applications in this exciting field.
BioPh Japan, focusing on biopharmaceutical development and services, brings bio solutions to CPhI Japan and is for companies and organisations involved in the research and development of new treatment methods arising from biotechnical processes or which are derived from, or use live organisms.
Structural economic reforms in Japan have fuelled a continued rally in biotechnology. The Japanese pharmaceutical manufacturers have been eager to catch up the US and European players in the bio field by investing and cooperating with bio ventures & universities.
The government has also been investing in infrastructure development such as bio industrial cluster projects and setting up support programs for bio ventures & universities in order to enhance Japan's bio pharma industry.
The markets for biologics such as antibodies, protein based drugs and vaccines have been increasing. Biotechnology-based drugs are anticipated to be one of the key drivers of the pharmaceutical market and this is reflected in the growing number biotechnology based drugs among newly approved medicines.
If you are dealing with the research and development of new treatment methods made through biotechnological processes or which are derived from or use live organisms or a supplier of bio pharma raw materials, services or equipment, don't miss this opportunity to benefit from the mix of exhibition and seminars at BioPh.
Owned by UBM plc listed on the London Stock Exchange, UBM Asia operates in 19 market sectors with headquarters in Hong Kong and subsidiary companies across Asia and in the US. We have over 280 products including trade fairs, conferences, trade publications, B2B/B2C portals and virtual event services. As Asia's leading exhibition organiser and the biggest commercial organiser in China, India and Malaysia, we stage the leading events of their kind across Asia. Our 200 events, 28 publications and 18 vertical portals serve a 1,000,000 quality exhibitors, visitors, conference delegates, advertisers and subscribers from all over the world with high value face-to-face business-matching events, quality and instant market news on market and industry trends and round-the-clock online trading networks and sourcing platforms. We have 1,200 staff in 25 major cities across Asia, stretching from Japan to Turkey.
bio, pharmaceutical ingredients, cphi, japan, drug, api, intermediates, fine chemicals, extracts, excipients, contract manufacturing, バイオピーエイチ, 再生医療, バイオ, 医薬品原料, シーピーエイチアイ, 日本, 薬, 原薬, 中間体, ファインケミカル, 抽出, 添加剤, 受託製造, ジャパンライフサイエンスウィーク